Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-25-000091·Arcturus Therapeutics Holdings Inc.
Schedule 13G ownership disclosure
Arcturus Therapeutics Holdings Inc
COMMON STOCK · CUSIP: 03969T109
Event date: 2024-12-31
- Filing-level shares
- 1,326,158.00
- Percent of class
- 4.9%
- STATE STREET CORPORATION
Shares: 1,326,158.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000091
- Form type
- SCHEDULE 13G
- Filer
- Arcturus Therapeutics Holdings Inc.
- CIK
- CIK 1768224
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership